Cleared Traditional

K182703 - EntericBio Dx Assay (FDA 510(k) Clearance)

Jun 2019
Decision
265d
Days
Class 2
Risk

K182703 is an FDA 510(k) clearance for the EntericBio Dx Assay. This device is classified as a Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-based Assay System (Class II - Special Controls, product code PCH).

Submitted by Serosep , Ltd. (Annacotty, IE). The FDA issued a Cleared decision on June 19, 2019, 265 days after receiving the submission on September 27, 2018.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3990. A Gastrointestinal Pathogen Panel Multiplex Nucleic Acid Assay Is A Qualitative In Vitro Diagnostic Device Intended To Simultaneously Detect And Identify Multiple Gastrointestinal Microbial Nucleic Acids Extracted From Human Stool Specimens. The Detection And Identification Of A Specific Gastrointestinal Microbial Nucleic Acid From Individuals Exhibiting Signs And/or Symptoms Of Gastrointestinal Infection Aids In The Diagnosis Of Gastrointestinal Infection When Used In Conjunction With Clinical Evaluation And Other Laboratory Findings..

Submission Details

510(k) Number K182703 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 27, 2018
Decision Date June 19, 2019
Days to Decision 265 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code PCH - Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-based Assay System
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3990
Definition A Gastrointestinal Pathogen Panel Multiplex Nucleic Acid Assay Is A Qualitative In Vitro Diagnostic Device Intended To Simultaneously Detect And Identify Multiple Gastrointestinal Microbial Nucleic Acids Extracted From Human Stool Specimens. The Detection And Identification Of A Specific Gastrointestinal Microbial Nucleic Acid From Individuals Exhibiting Signs And/or Symptoms Of Gastrointestinal Infection Aids In The Diagnosis Of Gastrointestinal Infection When Used In Conjunction With Clinical Evaluation And Other Laboratory Findings.

Similar Devices - PCH Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-based Assay System

All 10
QIAstat-Dx Gastrointestinal Panel 2
K254032 · QIAGEN GmbH · Mar 2026
Xpert GI Panel
K251721 · Cepheid · Jan 2026
QIAstat-Dx Gastrointestinal Panel 2
K252329 · QIAGEN GmbH · Oct 2025
Panther Fusion GI Bacterial Assay
K251868 · Hologic · Sep 2025
Panther Fusion GI Expanded Bacterial Assay
K251993 · Hologic, Inc. · Sep 2025
BIOFIRE FILMARRAY Gastrointestinal (GI) Panel Mid
K243885 · Biofire Diagnostics, LLC · Jan 2025